MEDASENSE - Key Persons
Job Titles:
- Member of the Board
- Co - Founder and Partner at OTV
Alejandro Weinstein is the co-founder and Partner at OTV ventures and WM Partners, and has more than 36 years of experience in the pharmaceutical industry. Prior to founding OTV and WM Partners, Mr. Weinstein was the CEO of CFR Pharmaceuticals S.A. ("CFR"), where he was responsible for a series of acquisitions transforming CFR from a local Chilean pharmaceutical company into a major global pharmaceutical company with presence in 26 countries across three continents. Under Mr. Weinstein's leadership CFR completed an initial public offering and in September 2014, the Company was sold to Abbott Laboratories for approximately $2.9 billion.
In addition to his role as Board Member at Medasense Biometrics Ltd., Mr. Weinstein holds director or investor roles in various ventures in the pharmaceutical and healthcare industries, including Olive Tree Ventures, Vanterra and Davidson & W. He is a board member of Health Hero, Atida, Medneo GmbH, Grupo Procaps and Gauzy Ltd.
Mr. Weinstein received a Business and Administration degree from the Universidad Catolica de Chile and is a certified public auditor and accountant. He also a graduate of the OPM program at Harvard Business School.
Job Titles:
- Member of the Board
- Member of the Scientific Advisory Board
Dr. Levy brings to Medasense over forty years of experience in the medical device industry. He spent twenty years at Johnson & Johnson developing many successful medical products and served in numerous leadership roles....
He then established and led multiple medical device companies, including Heartstream, that developed the first small, lightweight and easy-to-use automated external defibrillator.
Dr. Levy has also served as a Senior Advisor at Frazier Healthcare Ventures. He currently serves on the boards of multiple private and public healthcare companies.
Dr. Levy holds a BSc in Chemistry from City College of New York and a PhD and Honorary DSc from Purdue University.
Job Titles:
- Chief
- Member of the Scientific Advisory Board
Dr. Gilligan is the Chief, Division of Pain Medicine, Department of Anesthesiology Perioperative and Pain Medicine at the Brigham and Women's Hospital (BWH), and also an Assistant Professor in Anesthesia at Harvard Medical School. He was formerly the Director of the Massachusetts General Hospital Center for Pain Medicine....
Dr. Gilligan graduated with honors from Harvard University and received an MPhil from Cambridge University. He received his medical degree with honors from Yale University School of Medicine and was a resident in general surgery at Brigham & Women's Hospital. He completed residency training in Emergency Medicine at the Harvard-affiliated emergency medicine residency and fellowship training in pain medicine at Massachusetts General Hospital.
He received an MBA from Harvard Business School and was a senior associate at TVM Capital.
Job Titles:
- Member of the Board
- Member of the Scientific Advisory Board
Douglas M. Hansell, MD, MPH is the Vice President, Head of Medical Affairs, Medication Delivery, Acute Therapies & Clinical Nutrition at Baxter International Inc.
Dr Hansell has experience in large company MedDevice, healthcare startups, biotech & venture capital. Prior to Baxter, Dr. Hansell led the medical strategy that helped Cheetah Medical grow from startup to acquisition by Baxter in 4 years. Prior to Cheetah, Dr. Hansell was Chief Medical Officer for GE Healthcare and Covidien (Medtronic). Prior to industry, Dr. Hansell was CMO of an IDN in Boston. Alongside industry, he has a 30+ year academic career at Massachusetts General Hospital and Harvard Medical School in Boston.
Job Titles:
- Member of the Scientific Advisory Board
- FCCM
Dr. Barr, MD, FCCM, is an Associate Professor of Anesthesiology Perioperative, and Pain Medicine in the Medical Center Line at Stanford, and a Staff Anesthesiologist and Intensivist at the VA Palo Alto Medical Center. She is board certified in internal medicine, anaesthesiology, and critical care medicine....
Dr. Barr was the lead author of the Society of Critical Care Medicine's (SCCM) 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit. Dr. Barr has published 48 peer-reviewed manuscripts and book chapters. She is currently a national faculty member of the SCCM's ICU Liberation Campaign ABCDEF Bundle Collaborative in the U.S.
Dr. Cabilly is an investor and a board member of several companies. Dr. Cabilly developed a new technology for recombinant antibody production during a post-doctoral fellow at Genentech. This invention was patented in world patents known as "The Old Cabilly" and "The New Cabilly" patents....
Job Titles:
- VP of Sales, EMEA, LATAM, and APAC
Enrique Linaza brings over fifteen years of medical device business development experience. Prior to joining Medasense, he led business development in Iberia at Oticon Medical (Demant group) as well as other roles including Sales Director Eastern Europe & Asia focused on cochlear implant hearing solutions. Throughout his career, Enrique has worked for big global structures and with local distributors gaining experience in growing both new and mature businesses at different stages of the product life cycle in both public and private health systems. ...
He couples hands-on clinical knowledge with commercial strategy, leading teams to achieve commercial success.
Enrique holds an Executive MBA from the IE Business School, an MSc from UCAM University and a physiotherapy degree from CEU University.
Job Titles:
- CEO
- Founder
- Member of the Board
- Member of the Scientific Advisory Board
Galit Zuckerman Stark brings to Medasense over twenty years of entrepreneurship, management and engineering experience in both start-ups and large corporations. She founded Medasense upon discovering that while advanced algorithms are used frequently in many different industries such as semiconductors, communication, and many others, the discipline of medicine and specifically pain was still left behind....
Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Galit started her technology career at the elite Israeli Defense Forces "Haman Talpiot" program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.
Galit holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.
Mr. Weinstein has more than eight years' experience as executive and investor in the life sciences industry. He most recently served as Vice President of Innovation and Development at Abbott Laboratories. Prior to that he was Vice President of Strategy and Innovation at CFR Pharmaceuticals....
He has a proven track record of launching over 300 products in the pharmaceutical industry in Latin America and completing more than 20 licensing deals including biotech products and medical devices. He currently serves as a Board Member of Convexity Scientific, Via Surgical and Dog Parker. He previously served on the board of BMRC, a biotech research consortium in Chile.
Job Titles:
- VP of SALES, NORTH AMERICA
With over 30 years of experience in healthcare across the Americas, Holly Stewart's expertise lies in launching cutting-edge technologies in healthcare and building high-functioning and successful teams. She has held and excelled in sales, marketing, clinical, people and distribution management roles with Medtronic, Covidien, Oridion, SafeBVM, and BOMImed. ...
Holly and her teams have assisted thousands of customers in implementing and adopting new technologies across the care continuum. Most recently she started her own consulting business, MedMERIT Consulting, LLC, to bring new technologies to the market that improve patient safety, outcomes, and quality of life.
Holly holds a BSc in Business Administration from Capella University and an Associate Degree in Respiratory Therapy from SAIT. She resides in Texas with her family.
Job Titles:
- MembeR of the Board
- Managing Partner, President and Co - Founder at the Venture Capital Firm ASABYS Partners
Job Titles:
- Chairman of the Board
- Member of the Scientific Advisory Board
Mr. Kaufman served as Corporate Vice President of Applied Materials Previously Mr. Kaufman was the founder and President of KLA Instruments Israel, and General Manager of Kulicke and Soffa Israel. Currently, he serves as chairman and director of several high-tech companies. Mr. Kaufman holds engineering degrees from the Technion - Israel Institute of Technology.
Maite leads Corporate Development & Investments at Asabys Partners. She joined the firm in 2019 and is primary focused in supporting the firm's healthtech portfolio with their development, expansion and exit strategies. Prior to joining Asabys, Maite led Business Development at Sphera Global Healthcare, telemedicine company with operations in Europe, Latam and Africa....
Previously, she was incubating tech companies (healthtech, insurtech, wellness, etc.) at Antai Ventures, leading venture builder in Southern Europe. Maite started her professional career at Deloitte Corporate Finance, unit responsible for M&A and debt restructuring operations in Spain.
Currently doing a graduate program at Harvard University in Corporate Innovation and Sustainability, Maite holds a bachelor's degree in International Business from Pompeu Fabra University (UPF) and the University of Florida (Warrington College of Business), and a master's degree in Digital Marketing by ISDI.
As a versatile and experienced R&D professional, Ofir Gur has a passion for innovation and a proven track record of success in managing and delivering complex projects in key roles across a variety of organizations. His expertise encompasses a wide range of technologies, from cloud-based systems to low-level embedded projects.
Before Medasense, Ofir lead a team in the Technology Research & Innovation group at Perion and later was a part of the CTO office leading adoptions of new technologies (NASDAQ: PERI).
He is skilled at building and leading high-performing teams, coordinating complex tasks and activities, and driving results in challenging, ever-changing environments.
Job Titles:
- Member of the Scientific Advisory Board
- Editor for Anesthesiology
- Founder and Director of the Outcomes Research Consortium
Prof. Sessler is Founder and Director of the Outcomes Research Consortium - the world's largest clinical anaesthesia research group, and is currently the Michael Cudahy Professor and Chair of the Department of Outcomes Research at Cleveland Clinic....
Prof. Sessler attended medical school at Columbia University, and subsequently completed pediatric and anaesthesia residencies at the University of California, Los Angeles. He later served as a Professor at the University of California in San Francisco and as Vice-dean for Research at the University of Louisville.
Prof. Sessler is an editor for Anesthesiology and serves as a reviewer for more than 50 journals. He has published a book on therapeutic hypothermia and more than 800 full research papers including several dozen in the New England Journal of Medicine, Lancet and JAMA. His papers have been cited more than 37,000 times, and 100 were accompanied by editorials.
Prof. Sessler founded and directs the Outcomes Research Consortium, a group that publishes a full paper every three days. He also serves as a director of the Foundation for Anesthesia Education and Research (FAER). Among his awards is a Fulbright Fellowship and the American Society of Anesthesiology Excellence in Research prize.
Job Titles:
- Member of the Scientific Advisory Board
- Director of the Multidisciplinary Pain Relief Unit at Rambam Medical Center
Prof. Eisenberg is Director of the Multidisciplinary Pain Relief Unit at Rambam Medical Center, and is also a professor at the Ruth and Bruce Rappaport Faculty of Medicine of the Technion - Israel Institute of Technology. His main areas of research include mechanisms and treatment of neuropathic pain including CRPS, cancer pain, opioids and electrical stimulation....
Prof. Eisenberg has published over 150 articles, book chapters and abstracts on various areas of pain. He is former Chairman of the executive board of the Israeli Pain Association. Prof. Eisenberg has been a member of Medasense's scientific advisory board since its inception in 2008.
Prof. Eisenberg graduated from Sackler School of Medicine, Tel Aviv University, completed a residency in Neurology at Rambam Medical Center, Haifa Israel, and a Neurology-Pain Fellowship at Massachusetts General Hospital, Harvard Medical School in Boston.
Job Titles:
- Member of the Scientific Advisory Board
- VP Clinical & Market Development
Rachel Weissbrod brings twenty years of experience in the medical device industry in clinical strategy and market development, regulatory affairs and quality assurance, product innovation and management. Prior to joining Medasense, Rachel was a Global Director of Medical Affairs & Value Based Healthcare at Medtronic focusing on clinical market development for patient monitoring devices....
She has held leadership roles in Quality Assurance, Regulatory & Clinical Affairs at Covidien, Oridion Medical and additional start-up companies with extensive experience in leading teams in the development and execution of global regulatory, quality and clinical strategies supporting new product development and commercialization.
Rachel holds B.Pharm and MBA degrees from the Hebrew University of Jerusalem, Israel.
Mr. Gavshon migrated to Australia from South Africa in 1978 where he was a partner in one of the largest law firms in that country. In Australia, initially he acted as Group General Counsel and Director of Corporate Affairs with worldwide responsibility for a multinational corporation based in Sydney....
Mr. Gavshon was a significant shareholder in, and served as an Executive Director of private and listed companies which developed icon brands. He has gained broad business experience in Australasia, USA and Asia and has been involved in a number of successful equity ventures where he has also taken Board and advisory roles.
Mr. Gavshon is widely respected for the extensive community service he has given and occupied leading positions in the Australian not-for-profit sector. He holds commerce and law degrees from the University of Witwatersrand, South Africa.
Job Titles:
- CFO
- Member of the Scientific Advisory Board
Walter Tabachnik served as the Executive Vice President and Chief Financial Officer of Oridion Systems, a successful patient monitoring company. He led their successful acquisition by the global healthcare company, Covidien, for $346M in 2012. He later served as Covidien's Director of Strategy and Portfolio EMEA....
Previously Walter has held a number of senior accounting positions in various distinguished firms in Israel and South Africa. He is a certified public accountant in Israel and holds a BA in Accounting and Economics from the Hebrew University of Jerusalem, Israel.